StockData
Alumis Inc. logo

Alumis Inc. (ALMS) shareholders

ALMSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$4.39−0.45 (-9.19%)

Close on Nov 18, 2026Market cap $568.87MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
91.3%
118M of 129M shares
Institutional holders
198
30 new, 24 sold out
Net institutional buying
5M
In Q2 2026
Insider trades, 12 months
28 buys · 15 sales
Net bought $52.50M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
James B. Tananbaum15,693,82012.70%13D (active) amendmentApr 1, 2026
AyurMaya Capital Management Company, LP
Joint filing with David E. Goel (12.30%)
15,139,70712.30%13D (active) amendmentMay 14, 2026
Deep Track Biotechnology Master Fund, Ltd.
Joint filing with Deep Track Capital, LP (5.98%), David Kroin (5.98%)
7,362,0355.98%13G (passive)Mar 30, 2026
BlackRock, Inc.7,069,5025.70%13G (passive)Jun 30, 2026
FMR LLC
Joint filing with Abigail P. Johnson (5.50%)
6,769,1705.50%13G (passive)Jun 30, 2026
Srinivas Akkaraju6,345,2195.40%13D (active) amendmentJan 9, 2026
Samsara BioCapital GP, LLC
Joint filing with Samsara BioCapital, L.P. (5.00%), Srinivas Akkaraju (5.00%)
4,801,3705.00%13D (active) amendmentMay 21, 2025

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of ALMSValueChange% of portfolio
AyurMaya Capital Management Company, LP15,139,70711.70%$426.03M–100.00%
BlackRock, Inc.8,218,1516.35%$231.26M+1,047,2830.00%
FMR LLC6,769,1705.23%$190.48M+5,795,3880.01%
Deep Track Capital, LP6,348,5584.90%$178.65M−424,0372.60%
Samsara BioCapital, LLC6,345,2194.90%$178.55M–14.67%
Foresite Capital Management V, LLC5,896,9954.56%$165.94M–45.81%
Price T Rowe Associates Inc /Md/5,199,8384.02%$146.33M+1,913,0850.01%
venBio Partners LLC4,528,4083.50%$127.43M–24.53%
Foresite Capital Management VI LLC4,247,6703.28%$119.53M–18.60%
Vanguard Capital Management LLC4,215,7033.26%$118.63M+183,4370.00%
Nextech Invest, Ltd.3,540,9982.74%$99.64M–4.73%
Cormorant Asset Management, LP3,285,5962.54%$92.46M−663,6454.74%
Saturn V Capital Management LP2,915,4432.25%$82.04M−286,63211.76%
Octagon Capital Advisors LP2,830,7002.19%$79.66M–7.16%
Jupiter Topco LLC2,355,1221.82%$66.24MNew0.03%
State Street Corp2,187,2661.69%$61.55M+385,4540.00%
Geode Capital Management, LLC2,168,5171.68%$61.03M+250,1020.00%
Mpm Bioimpact LLC2,019,0201.56%$56.82M−367,5093.46%
Baker Bros. Advisors LP2,012,5001.55%$56.63M–0.28%
Sr One Capital Management, LP1,959,8961.51%$55.15M–5.31%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026198118M91.3%30 / 7461 / 2417M11M
Q1 2026196115M88.7%89 / 6133 / 2444M5M
Q4 202513479M61.1%30 / 4734 / 2515M13M
Q3 202513078M60.5%33 / 3830 / 156M6M
Q2 202511278M60.5%53 / 492 / 1338M0M
Q1 20257240M31.1%20 / 295 / 103M1M
Q4 20246440M31.1%15 / 247 / 35M0M
Q3 20245235M27.2%35 / 55 / 128M1M
Q2 20242929M22.1%29 / 00 / 029M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

199 funds held ALMS in Q2 2026, 49% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of ALMSValue% of fundAs of
Vanguard Total Stock Market Index Fund3,139,7562.43%$88.35M0.00%Jun 30, 2026
iShares Russell 2000 ETF2,020,2851.56%$56.85M0.07%Jun 30, 2026
T. Rowe Price New Horizons Fund, Inc.1,369,9161.06%$38.55M0.26%Jun 30, 2026
Fidelity Small Cap Growth Fund1,103,4700.85%$31.17M0.35%Jul 31, 2026
Fidelity Stock Selector Small Cap Fund1,103,0000.85%$31.16M0.42%Jul 31, 2026
T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund1,088,3000.84%$30.62M0.31%Jun 30, 2026
Vanguard Extended Market Index Fund977,0980.75%$27.50M0.03%Jun 30, 2026
Fidelity Advisor Biotechnology Fund946,5000.73%$26.74M1.22%Jul 31, 2026
Fidelity Small Cap Index Fund863,9160.67%$24.41M0.07%Jul 31, 2026
iShares Russell 2000 Growth ETF682,0350.53%$19.19M0.12%Jun 30, 2026
Fidelity Series Small Cap Opportunities Fund633,3000.49%$17.89M0.38%Jul 31, 2026
Select Biotechnology Portfolio620,0000.48%$13.39M0.25%May 31, 2026
T. Rowe Price Health Sciences Fund, Inc.594,9230.46%$16.74M0.14%Jun 30, 2026
iShares Biotechnology ETF594,1250.46%$16.72M0.18%Jun 30, 2026
Fidelity Small Cap Growth K6 Fund572,4600.44%$16.17M0.35%Jul 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Martin BablerPresident, CEO and Chairman, Director109,4540.08%Jan 28, 2026
Sanam PangaliChief Legal Officer9,4150.01%Nov 4, 2026
Mark Christopher BradleyChief Development Officer67,9360.05%Nov 4, 2026
John R. SchroerChief Financial Officer23,9240.02%Nov 4, 2026
Roy C. HardimanChief Business & Strategy Ofcr213,5110.16%Nov 4, 2026
David M. GoldsteinChief Scientific Officer247,5720.19%Nov 4, 2026
Jorn DrappaChief Medical Officer56,2990.04%Nov 4, 2026
Derrick RichardsonSVP, People and Culture42,8000.03%Jul 31, 2025
Sara KleinChief Legal Officer33,7960.03%Feb 20, 2025
Srinivas AkkarajuDirector6,966,0725.38%Sep 9, 2026
Patrick MachadoDirector10,6170.01%Jul 2, 2026
Lynn A. TetraultDirector3,5530.00%Jul 2, 2026
Sapna SrivastavaDirector3,5530.00%Jul 2, 2026
Zhengbin YaoDirector27,0820.02%Jul 2, 2026
James B. TananbaumDirector, 10% owner1,123,3370.87%Apr 3, 2026
David E. GoelDirector, 10% owner10,645,9668.22%May 23, 2025
AyurMaya Capital Management Company, LPDirector, 10% owner15,139,70711.70%May 23, 2025
Alan ColowickDirector18,4040.01%Apr 3, 2025
Foresite Capital Fund V, L.P.10% owner––Apr 3, 2026
Foresite Capital Opportunity Fund V, L.P.10% owner––Apr 3, 2026
Foresite Capital Opportunity Management V, LLC10% owner3,067,5712.37%Apr 3, 2026
Foresite Labs Affiliates 2021, LLC10% owner0–Apr 3, 2026
Foresite Labs Fund I, L.P.10% owner2,908,3322.25%Apr 3, 2026
Foresite Labs Management I, LLC10% owner4,247,6703.28%Apr 3, 2026
Labs Co-Invest V, LLC10% owner––Apr 3, 2026
Capital Fund VI LP Foresite10% owner––Apr 3, 2026
Foresite Labs, LLC10% owner2,908,3322.25%Apr 3, 2026
Foresite Capital Management V, LLC10% owner––Apr 3, 2026
Capital Management VI LLC Foresite10% owner1,123,3370.87%Apr 3, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Sanam Pangali
Chief Legal Officer
Nov 2, 2026Sale−332$6.52$2.16K9,415
Mark Christopher Bradley
Chief Development Officer
Nov 2, 2026Sale−623$6.52$4.06K47,910
Jorn Drappa
Chief Medical Officer
Nov 2, 2026Sale−593$6.52$3.87K56,299
David M. Goldstein
Chief Scientific Officer
Nov 2, 2026Sale−629$6.52$4.10K30,341
John R. Schroer
Chief Financial Officer
Nov 2, 2026Sale−794$6.52$5.18K23,924
Roy C. Hardiman
Chief Business & Strategy Ofcr
Nov 2, 2026Sale−652$6.52$4.25K207,094
Srinivas Akkaraju
Director
Sep 8, 2026Sale−48,065$10.55$507.09K2,025,493
Srinivas Akkaraju
Director
Sep 8, 2026Buy+273,290$10.63$2.91M2,298,783
Srinivas Akkaraju
Director
Sep 8, 2026Buy+273,291$10.63$2.91M4,937,026
Srinivas Akkaraju
Director
Sep 8, 2026Sale−48,066$10.55$507.10K4,663,735
Srinivas Akkaraju
Director
Sep 4, 2026Buy+220,070$11.17$2.46M4,711,801
Srinivas Akkaraju
Director
Sep 4, 2026Buy+220,070$11.17$2.46M2,073,558
Roy C. Hardiman
Chief Business & Strategy Ofcr
Aug 3, 2026Sale−2,692$26.37$70.99K207,746
David M. Goldstein
Chief Scientific Officer
Aug 3, 2026Sale−2,596$26.37$68.46K30,970
Jorn Drappa
Chief Medical Officer
Aug 3, 2026Sale−2,447$26.37$64.53K56,892
Mark Christopher Bradley
Chief Development Officer
Aug 3, 2026Sale−2,572$26.37$67.82K48,533
Sanam Pangali
Chief Legal Officer
Aug 3, 2026Sale−1,364$26.37$35.97K9,747
John R. Schroer
Chief Financial Officer
Aug 3, 2026Sale−3,282$26.37$86.55K24,718
Sanam Pangali
Chief Legal Officer
Jul 6, 2026Sale−5,000$28.00$140.00K11,111
Sanam Pangali
Chief Legal Officer
Jul 6, 2026Option exercise+5,000$5.06$25.30K16,111
Zhengbin Yao
Director
Jun 30, 2026Award+3,553––27,082
Srinivas Akkaraju
Director
Jun 30, 2026Award+3,553––3,553
Sapna Srivastava
Director
Jun 30, 2026Award+3,553––3,553
Lynn A. Tetrault
Director
Jun 30, 2026Award+3,553––3,553
Patrick Machado
Director
Jun 30, 2026Award+3,553––3,553
Jorn Drappa
Chief Medical Officer
May 22, 2026Option exercise+11,317$8.84$100.04K43,804
Jorn Drappa
Chief Medical Officer
May 22, 2026Option exercise+15,535$5.06$78.61K59,339
Foresite Labs Affiliates 2021, LLC
10% owner
Apr 1, 2026Other−1,123,337––0
Foresite Labs Affiliates 2021, LLC
10% owner
Apr 1, 2026Other−1,176,470––0
Foresite Labs Affiliates 2021, LLC
10% owner
Apr 1, 2026Other+680,486––680,486
Foresite Labs Affiliates 2021, LLC
10% owner
Apr 1, 2026Other+1,123,337––1,123,337
Capital Management VI LLC Foresite
10% owner
Apr 1, 2026Other+1,123,337––1,123,337
Capital Management VI LLC Foresite
10% owner
Apr 1, 2026Other+680,486––680,486
Capital Management VI LLC Foresite
10% owner
Apr 1, 2026Other−1,123,337––0
Capital Management VI LLC Foresite
10% owner
Apr 1, 2026Other−1,176,470––0
James B. Tananbaum
Director, 10% owner
Apr 1, 2026Other+1,123,337––1,123,337
James B. Tananbaum
Director, 10% owner
Apr 1, 2026Other−1,176,470––0
James B. Tananbaum
Director, 10% owner
Apr 1, 2026Other−1,123,337––0
James B. Tananbaum
Director, 10% owner
Apr 1, 2026Other+680,486––680,486
Srinivas Akkaraju
Director
Jan 9, 2026Buy+588,235$17.00$10.00M1,853,488
Foresite Labs, LLC
10% owner
Jan 8, 2026Buy+294,117$17.00$5.00M2,908,332
Foresite Labs, LLC
10% owner
Jan 8, 2026Buy+117,647$17.00$2.00M5,702,536
James B. Tananbaum
Director, 10% owner
Jan 8, 2026Buy+117,647$17.00$2.00M5,702,536
James B. Tananbaum
Director, 10% owner
Jan 8, 2026Buy+294,117$17.00$5.00M2,908,332
Foresite Labs Fund I, L.P.
10% owner
Jan 8, 2026Buy+294,117$17.00$5.00M2,908,332
Foresite Labs Fund I, L.P.
10% owner
Jan 8, 2026Buy+117,647$17.00$2.00M5,702,536
Srinivas Akkaraju
Director
Dec 5, 2025Buy+64,969$8.95$581.47K1,143,845
Srinivas Akkaraju
Director
Dec 5, 2025Buy+51,380$10.73$551.31K1,265,253
Srinivas Akkaraju
Director
Dec 5, 2025Buy+70,028$10.01$700.98K1,213,873
Srinivas Akkaraju
Director
Dec 4, 2025Buy+66,027$8.18$540.10K1,078,876
Srinivas Akkaraju
Director
Dec 3, 2025Buy+100,000$7.75$775.00K1,012,849
Srinivas Akkaraju
Director
Dec 2, 2025Buy+96,000$7.55$724.80K912,849
Srinivas Akkaraju
Director
Dec 1, 2025Buy+86,350$7.46$644.17K816,849
Srinivas Akkaraju
Director
Nov 28, 2025Buy+38,702$7.64$295.68K730,499
Srinivas Akkaraju
Director
Nov 26, 2025Buy+48,537$7.64$370.82K691,797
Foresite Labs Fund I, L.P.
10% owner
Nov 21, 2025Buy+72,212$7.38$532.92K2,614,215
Foresite Labs Affiliates 2021, LLC
10% owner
Nov 21, 2025Buy+72,212$7.38$532.92K2,614,215
James B. Tananbaum
Director, 10% owner
Nov 21, 2025Buy+72,212$7.38$532.92K2,614,215
Srinivas Akkaraju
Director
Nov 20, 2025Buy+125,743$7.20$905.35K643,260
Foresite Labs Affiliates 2021, LLC
10% owner
Nov 19, 2025Buy+190,500$6.56$1.25M2,542,003

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
12.27%
11M shares short
Days to cover
5.8
At 2M shares a day
Change since last report
-0.4%
From 11M shares
Short volume, 20 days
35.1%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Alumis's stock actually held short. Settlement fails (shares not delivered on time) peaked at 390,745 shares on Sep 2, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Sanampreet Pangali
Officer
Jul 6, 20265,000$140.00KJul 6, 2026Stock Option Exercise

See a number that looks wrong?